News
Meet us at...
Forum Life Science 2013 13./14. March 2013, Munich / Garching; Talk: "Cell-based tehrapeutics on the way to the clinical application", Dr. Christine Günther, CEO, apceth GmbH & Co. KG
04.02.2013 Press release
apceth received the second round of funding for its innovative stem cell-based cancer therapeutic as part of the m4 initiative of the Munich Biotech Cluster
Meet us at...
10th Annual Commercial Translation of Regenerative Medicine, 28-30 November 2012, Hotel Hilton Kensington, London, UK
apceth‘s article
Zell- und Gentherapie in der Regenerativen Medizin (Cell- and Gene Therapy in Regenerative Medicine) [more]
apceth’s article
GMP-gerechte Kultur von mesenchymalen Stammzellen (GMP-compliant culture of mesenchymal stem cells) [more]
Opening in Ottobrunn
12 March 2012 sees the formal opening of apceth's new production site in Ottobrunn (near Munich). A GMP production licence for cell therapeutics has already been issued. This constitutes an extension of apceth's resources both for its own ... [more]